157 related articles for article (PubMed ID: 29090518)
1. Detection and analysis of circulating large intergenic non-coding RNA regulator of reprogramming in plasma for breast cancer.
Zhang K; Luo Z; Zhang Y; Wang Y; Cui M; Liu L; Zhang L; Liu J
Thorac Cancer; 2018 Jan; 9(1):66-74. PubMed ID: 29090518
[TBL] [Abstract][Full Text] [Related]
2. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
Zhao T; Wu L; Li X; Dai H; Zhang Z
Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
[TBL] [Abstract][Full Text] [Related]
3. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
4. Circulating long non-coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer.
Zhang Y; Zhang K; Luo Z; Liu L; Wu L; Liu J
Thorac Cancer; 2016 Nov; 7(6):627-632. PubMed ID: 27755794
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
Lu PW; Li L; Wang F; Gu YT
J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA lincRNA-ROR Promotes the Progression of Colon Cancer and Holds Prognostic Value by Associating with miR-145.
Zhou P; Sun L; Liu D; Liu C; Sun L
Pathol Oncol Res; 2016 Oct; 22(4):733-40. PubMed ID: 27071407
[TBL] [Abstract][Full Text] [Related]
7. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells.
Chen YM; Liu Y; Wei HY; Lv KZ; Fu P
Tumour Biol; 2016 Aug; 37(8):10861-70. PubMed ID: 26883251
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of long non-coding RNA-ROR in cancer patients: A systematic review and meta-analysis.
Luo D; Yang L; Yu L; Chen Y; Huang Z; Liu H
Medicine (Baltimore); 2021 Jul; 100(27):e26535. PubMed ID: 34232190
[TBL] [Abstract][Full Text] [Related]
9. Expression and Functional Role of Reprogramming-Related Long Noncoding RNA (lincRNA-ROR) in Glioma.
Feng S; Yao J; Chen Y; Geng P; Zhang H; Ma X; Zhao J; Yu X
J Mol Neurosci; 2015 Jul; 56(3):623-30. PubMed ID: 25651893
[TBL] [Abstract][Full Text] [Related]
10. The long noncoding RNA-ROR promotes the resistance of radiotherapy for human colorectal cancer cells by targeting the p53/miR-145 pathway.
Yang P; Yang Y; An W; Xu J; Zhang G; Jie J; Zhang Q
J Gastroenterol Hepatol; 2017 Apr; 32(4):837-845. PubMed ID: 27696511
[TBL] [Abstract][Full Text] [Related]
11. Association of lncRNA-p53 regulatory network (lincRNA-p21, lincRNA-ROR and MALAT1) and p53 with the clinicopathological features of colorectal primary lesions and tumors.
Chaleshi V; Irani S; Alebouyeh M; Mirfakhraie R; Aghdaei HA
Oncol Lett; 2020 Jun; 19(6):3937-3949. PubMed ID: 32391102
[TBL] [Abstract][Full Text] [Related]
12. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.
Han L; Ma P; Liu SM; Zhou X
Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314
[TBL] [Abstract][Full Text] [Related]
13. Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer.
Zhang L; Song X; Wang X; Xie Y; Wang Z; Xu Y; You X; Liang Z; Cao H
Breast Cancer Res Treat; 2015 Jul; 152(1):199-208. PubMed ID: 26033707
[TBL] [Abstract][Full Text] [Related]
14. [Long non-coding RNA HOTAIR in plasma as a potential biomarker for breast cancer diagnosis].
Zhang KJ; Zhang Y; Luo ZL; Liu L; Yang J; Wu LC; Yu SS; Liu JB
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):488-92. PubMed ID: 27113175
[TBL] [Abstract][Full Text] [Related]
15. Differential Expression of
Saadat Akhtar M; Gholipour A; Bagheri Moghaddam M; Oveisee M; Mowla SJ; Malakootian M
Iran J Public Health; 2023 Feb; 52(2):427-435. PubMed ID: 37089151
[TBL] [Abstract][Full Text] [Related]
16. LincRNA-RoR/miR-145 promote invasion and metastasis in triple-negative breast cancer via targeting MUC1.
Ma J; Yang Y; Huo D; Wang Z; Zhai X; Chen J; Sun H; An W; Jie J; Yang P
Biochem Biophys Res Commun; 2018 Jun; 500(3):614-620. PubMed ID: 29673594
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
Miao Y; Fan R; Chen L; Qian H
Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
[TBL] [Abstract][Full Text] [Related]
18. The Emerging Roles of Long Noncoding RNA ROR (lincRNA-ROR) and its Possible Mechanisms in Human Cancers.
Pan Y; Li C; Chen J; Zhang K; Chu X; Wang R; Chen L
Cell Physiol Biochem; 2016; 40(1-2):219-229. PubMed ID: 27855392
[TBL] [Abstract][Full Text] [Related]
19. Serum lincRNA-p21 as a potential biomarker of liver fibrosis in chronic hepatitis B patients.
Yu F; Zhou G; Huang K; Fan X; Li G; Chen B; Dong P; Zheng J
J Viral Hepat; 2017 Jul; 24(7):580-588. PubMed ID: 28107589
[TBL] [Abstract][Full Text] [Related]
20. Potential Diagnostic Value of Plasma Long-Chain Non-Coding RNA HIT in Breast Cancer.
Hou H; Li F; Yang W; Wang H
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
